Envestnet Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.23M | Sell |
39,403
-3,447
| -8% | -$108K | ﹤0.01% | 3147 |
|
2025
Q1 | $1.44M | Sell |
42,850
-4,447
| -9% | -$149K | ﹤0.01% | 2954 |
|
2024
Q4 | $1.85M | Sell |
47,297
-1,539
| -3% | -$60.3K | ﹤0.01% | 2738 |
|
2024
Q3 | $1.92M | Sell |
48,836
-110
| -0.2% | -$4.33K | ﹤0.01% | 2683 |
|
2024
Q2 | $1.91M | Buy |
48,946
+769
| +2% | +$30K | ﹤0.01% | 2624 |
|
2024
Q1 | $2.07M | Buy |
48,177
+2,948
| +7% | +$127K | ﹤0.01% | 2549 |
|
2023
Q4 | $2.08M | Buy |
45,229
+1,127
| +3% | +$51.9K | ﹤0.01% | 2443 |
|
2023
Q3 | $1.51M | Buy |
44,102
+27,580
| +167% | +$942K | ﹤0.01% | 2525 |
|
2023
Q2 | $636K | Buy |
+16,522
| New | +$636K | ﹤0.01% | 3077 |
|